ASTH
Price
$40.31
Change
-$0.68 (-1.66%)
Updated
Jul 24 closing price
Capitalization
2B
12 days until earnings call
Intraday BUY SELL Signals
HCSG
Price
$22.74
Change
+$0.32 (+1.43%)
Updated
Jul 24 closing price
Capitalization
1.56B
95 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ASTH vs HCSG

ASTH vs HCSG Comparison Chart in %
View a ticker or compare two or three
VS
ASTH vs. HCSG commentary
Jul 25, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASTH is a StrongBuy and HCSG is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 25, 2026
Stock price -- (ASTH: $40.31 vs. HCSG: $22.74)
Brand notoriety: ASTH and HCSG are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: ASTH: 48% vs. HCSG: 76%
Market capitalization -- ASTH: $2B vs. HCSG: $1.56B
ASTH [@Hospital/Nursing Management] is valued at $2B. HCSG’s [@Hospital/Nursing Management] market capitalization is $1.56B. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $84.78B to $0. The average market capitalization across the [@Hospital/Nursing Management] industry is $4.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASTH’s FA Score shows that 1 FA rating(s) are green whileHCSG’s FA Score has 1 green FA rating(s).

  • ASTH’s FA Score: 1 green, 4 red.
  • HCSG’s FA Score: 1 green, 4 red.
According to our system of comparison, HCSG is a better buy in the long-term than ASTH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASTH’s TA Score shows that 4 TA indicator(s) are bullish while HCSG’s TA Score has 4 bullish TA indicator(s).

  • ASTH’s TA Score: 4 bullish, 5 bearish.
  • HCSG’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ASTH and HCSG are a bad buy in the short-term.

Price Growth

ASTH (@Hospital/Nursing Management) experienced а -10.30% price change this week, while HCSG (@Hospital/Nursing Management) price change was -10.15% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -2.50%. For the same industry, the average monthly price growth was +2.88%, and the average quarterly price growth was +25.57%.

Reported Earning Dates

ASTH is expected to report earnings on Aug 06, 2026.

HCSG is expected to report earnings on Oct 28, 2026.

Industries' Descriptions

@Hospital/Nursing Management (-2.50% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASTH($2B) has a higher market cap than HCSG($1.56B). ASTH has higher P/E ratio than HCSG: ASTH (66.07) vs HCSG (23.93). ASTH YTD gains are higher at: 62.475 vs. HCSG (18.933). ASTH has higher annual earnings (EBITDA): 163M vs. HCSG (96.8M). ASTH has more cash in the bank: 478M vs. HCSG (179M). HCSG has less debt than ASTH: HCSG (14.7M) vs ASTH (1.07B). ASTH has higher revenues than HCSG: ASTH (3.53B) vs HCSG (1.85B).
ASTHHCSGASTH / HCSG
Capitalization2B1.56B128%
EBITDA163M96.8M168%
Gain YTD62.47518.933330%
P/E Ratio66.0723.93276%
Revenue3.53B1.85B190%
Total Cash478M179M267%
Total Debt1.07B14.7M7,245%
FUNDAMENTALS RATINGS
ASTH vs HCSG: Fundamental Ratings
ASTH
HCSG
OUTLOOK RATING
1..100
8383
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
5
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8863
PRICE GROWTH RATING
1..100
3844
P/E GROWTH RATING
1..100
1099
SEASONALITY SCORE
1..100
47n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HCSG's Valuation (5) in the Servicestothe Health Industry industry is significantly better than the same rating for ASTH (73) in the null industry. This means that HCSG’s stock grew significantly faster than ASTH’s over the last 12 months.

HCSG's Profit vs Risk Rating (100) in the Servicestothe Health Industry industry is in the same range as ASTH (100) in the null industry. This means that HCSG’s stock grew similarly to ASTH’s over the last 12 months.

HCSG's SMR Rating (63) in the Servicestothe Health Industry industry is in the same range as ASTH (88) in the null industry. This means that HCSG’s stock grew similarly to ASTH’s over the last 12 months.

ASTH's Price Growth Rating (38) in the null industry is in the same range as HCSG (44) in the Servicestothe Health Industry industry. This means that ASTH’s stock grew similarly to HCSG’s over the last 12 months.

ASTH's P/E Growth Rating (10) in the null industry is significantly better than the same rating for HCSG (99) in the Servicestothe Health Industry industry. This means that ASTH’s stock grew significantly faster than HCSG’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASTHHCSG
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
70%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
69%
Momentum
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
67%
Advances
ODDS (%)
Bullish Trend 12 days ago
76%
Bullish Trend 9 days ago
69%
Declines
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 3 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
73%
Aroon
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
ASTH
Daily Signal:
Gain/Loss:
HCSG
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NRO3.060.06
+2.00%
Neuberger Real Estate Securities Income Fund Inc.
WNTR27.670.27
+0.99%
YieldMax MSTR Short Option Income Strategy ETF
FMAR52.270.07
+0.13%
FT Vest US Equity Buffer ETF Mar
PEVC29.48N/A
N/A
Pacer PE/VC ETF
EEMO20.51-0.90
-4.20%
Invesco S&P Emerging Markets Mom ETF

ASTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASTH has been loosely correlated with SGRY. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ASTH jumps, then SGRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASTH
1D Price
Change %
ASTH100%
-1.66%
SGRY - ASTH
34%
Loosely correlated
+3.35%
ACHC - ASTH
31%
Poorly correlated
+1.47%
HCA - ASTH
30%
Poorly correlated
+1.51%
NHC - ASTH
28%
Poorly correlated
+1.89%
HCSG - ASTH
27%
Poorly correlated
+1.40%
More

HCSG and

Correlation & Price change

A.I.dvisor indicates that over the last year, HCSG has been loosely correlated with NHC. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HCSG jumps, then NHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HCSG
1D Price
Change %
HCSG100%
+1.40%
NHC - HCSG
47%
Loosely correlated
+1.89%
ADUS - HCSG
36%
Loosely correlated
+2.35%
CON - HCSG
35%
Loosely correlated
+0.25%
THC - HCSG
32%
Poorly correlated
+17.17%
PNTG - HCSG
28%
Poorly correlated
+3.39%
More